What topics does this cannabis study cover?

This study covers research on: Endocannabinoid, Appetite, Inflammation.

Where was this research published?

Published in The Journal of physiology on May 11, 2026.

Endocannabinoid Appetite Inflammation

How chronic cannabis use may reverse obesity and improve glucose control

Δ9 Tetrahydrocannabinol and cannabis extracts differentially improve adipoinsular dysfunction in diet-induced obesity.

The Journal of physiology • May 11, 2026 • Moderately Relevant

🤖

AI Summary

This groundbreaking study reveals a paradoxical relationship between chronic cannabis use and weight management that contradicts the well-known "munchies" effect. Researchers found that chronic exposure to THC and cannabis extracts reduced body weight and fat mass in obese mice fed a high-fat diet, while simultaneously improving metabolic function. Importantly, cannabis extracts—but not THC alone—normalized glucose control in obese mice to levels comparable with lean mice, suggesting that whole-plant cannabis formulations may offer superior metabolic benefits compared to isolated cannabinoids.

The research uncovered a key mechanism behind these effects: cannabis compounds restore impaired communication between fat cells and the pancreas (adipoinsular axis), a critical system disrupted in obesity and type 2 diabetes. The study showed that cannabis extracts were more effective than pure THC at normalizing important metabolic signaling molecules (adipokines) that regulate this axis. In laboratory tests with fat cells, both THC and extracts promoted anti-adipogenic effects and altered cellular energy production, indicating cannabinoids directly influence how fat cells develop and function at the molecular level.

These findings help explain the epidemiological paradox: while acute cannabis consumption increases appetite, chronic users show lower rates of obesity and type 2 diabetes in real-world populations. The results suggest that long-term cannabinoid exposure may trigger metabolic adaptations that counteract weight gain. This has significant implications for developing cannabis-based therapies for metabolic disorders, though the superior performance of full extracts over isolated THC highlights the importance of the entourage effect—where multiple plant compounds work together more effectively than single isolated components.

📄 Original Abstract

Diet-induced obesity (DIO) is associated with dysregulated adipoinsular axis and endocannabinoid system (eCBS) function. Acute cannabis consumption stimulates appetite; however, chronic consumption is paradoxically associated with lower prevalence of human obesity and type 2 diabetes. We investigated the impact of chronic exposure to Δ9 tetrahydrocannabinol (THC) and cannabis extracts on DIO and glucose homeostasis in mice. Male mice were fed a high-fat/sucrose diet or a low-fat/no-sucrose diet for 60 days. At day 30, mice were administered THC (5 mg/kg) or cannabis extracts matched for THC content daily for 30 days. We assessed adipocyte biology, glucose tolerance, insulin sensitivity, eCBS expression, body weight, food intake and motor activity. Roles for the eCBS in cannabis-induced changes in metabolic processes, including cellular bioenergetics, were analysed in 3T3-L1 adipocytes. THC and extracts reduced body weight and fat mass in DIO mice, and reversed DIO-associated changes in expression of adipokines that regulate the adipoinsular axis. Extracts normalized expression of adipokines more effectively than THC. Notably, extracts - but not THC - normalized glucose clearance in DIO mice to levels found in lean mice. In addition, THC and extracts promoted anti-adipogenic effects and changes in energy metabolism in 3T3-L1 cells in a concentration-dependent manner. These studies suggest that chronic cannabinoid exposure improves metabolic function and dysregulated glucose homeostasis in DIO by a mechanism that includes restoring impaired adipoinsular axis function. KEY POINTS: Δ9 Tetrahydrocannabinol (Δ9THC) and cannabis extracts reduce body weight and fat mass in obese mice. Cannabis extracts, but not Δ9THC alone, improve glucose homeostasis in obese mice. Extracts more effectively normalize expression of components of the adipoinsular axis in obese mice. Δ9THC and extracts promote anti-adipogenic effects in 3T3-L1 cells. Δ9THC and extracts alter cellular bioenergetics in 3T3-L1 cells.

Paper Type

📄 Research

Publication

Journal: The Journal of physiology
Published: May 11, 2026
PMID: 42113966
DOI: 10.1113/JP290431

Authors (8)

Bryant Avalos Division of Biomedical Sciences, School of Medicine, University of California, Riverside, Riverside, California, USA.
Martin Olmos Division of Biomedical Sciences, School of Medicine, University of California, Riverside, Riverside, California, USA.
Courtney P Wood Division of Biomedical Sciences, School of Medicine, University of California, Riverside, Riverside, California, USA.
Camila Alvarez Division of Biomedical Sciences, School of Medicine, University of California, Riverside, Riverside, California, USA.
Haley M Read Department of Evolution, Ecology, and Organismal Biology, University of California, Riverside, Riverside, California, USA.
+3 more authors